The synthetic CB1 cannabinoid receptor selective agonists: Putative medical uses and their legalization-Reference-Cited by-同舟云学术

The synthetic CB1 cannabinoid receptor selective agonists: Putative medical uses and their legalization

Published:2021-08 Issue: Volume:110 Page:110301
ISSN:0278-5846
Container-title:Progress in Neuro-Psychopharmacology and Biological Psychiatry
language:en
Short-container-title:Progress in Neuro-Psychopharmacology and Biological Psychiatry

Author:

Coronado-Álvarez Astrid,Romero-Cordero Karen,Macías-Triana Lorena,Tatum-Kuri Agnes,Vera-Barrón Alba,Budde Henning,Machado Sérgio,Yamamoto Tetsuya,Imperatori Claudio,Murillo-Rodríguez Eric

Funder

UC MEXUS

Publisher

Elsevier BV

Subject

Biological Psychiatry,Pharmacology

Reference173 articles.

1. Cannabinoid receptor agonism suppresses tremor, cognition disturbances and anxiety-like behaviors in a rat model of essential tremor;Abbassian;Physiol. Behav.,2016

2. Medical use of cannabis and cannabinoids containing products – regulations in Europe and North America;Abuhasira;Eur. J. Int. Med.,2018

3. The effects of synthetic cannabinoid UR-144 on the human body-a review of 39 cases;Adamowicz;Forensic Sci. Int.,2017

4. Neuromolecular mechanisms of Cannabis action;Adel;Adv. Exp. Med. Biol.,2021

5. WIN 55,212-2, agonist of cannabinoid receptors, prevents amyloid β1-42 effects on astrocytes in primary culture;Aguirre-Rueda;PLoS One,2015

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of cannabinoid agonists and antagonists in male rats discriminating the synthetic cannabinoid AM2201;European Journal of Pharmacology;2023-12

2. CBD lengthens sleep but shortens ripples and leads to intact simple but worse cumulative memory;iScience;2023-11

3. Exploring the therapeutic potential of natural compounds modulating the endocannabinoid system in various diseases and disorders: review;Pharmacological Reports;2023-10-31

4. The endocannabinoid system as a putative target for the development of novel drugs for the treatment of psychiatric illnesses;Psychological Medicine;2023-09-06

5. The Role of Endocannabinoid System in Neuroprotection: Molecular Targets and Therapeutic Opportunities;Integrative Medicine Reports;2023-07-01